-
Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs
March 4, 2024 -
Aclarion Announces Closing of $3.0 Million Public Offering
February 27, 2024 -
Aclarion Announces Pricing of $3.0 Million Public Offering
February 26, 2024
Corporate Overview
Aclarion is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes and return patients to full, pain-free lives. The company’s first solution will address unmet needs in the low back and neck pain market. To learn more, visit www.aclarion.com.